Insiders · Profile

MILNE GEORGE M JR

Director at Amylyx Pharmaceuticals · Director at Aurinia Pharmaceuticals · Director at Charles River Laboratories · and 1 more. Filing since 21 May 2007. CIK 0001179552

Company
Date
Role
Action
Shares
Amount
Of holding
5 Oct 2026
Director
Sold on a plan
30,000
$830.90K
3.7%
3 Sep 2024
Director
Bought
100,000
$219.80K
13.2%
16 Mar 2023
Director
Sold at will
35,000
$1.12M
3.9%
2 Mar 2023
Director
Bought
20,000
$178.28K
40.0%
4 Mar 2022
Director
Bought
5,000
$54.10K
11.1%
6 Jan 2022
Director
Bought
26,315
$499.99K
13.5%
5 Mar 2021
Director
Bought
5,000
$65.00K
12.5%
1 Mar 2021
Director
Sold, plan not stated
3,530
$1.02M
11.0%
18 Feb 2020
Director
Sold, plan not stated
7,170
$1.26M
21.0%
22 Feb 2019
Director
Sold, plan not stated
4,540
$649.22K
15.7%
9 Mar 2018
Director
Sold, plan not stated
7,740
$890.10K
21.1%
14 Feb 2017
Director
Sold, plan not stated
10,710
$926.63K
27.3%
23 Feb 2016
Director
Sold, plan not stated
10,440
$762.32K
27.3%
22 Feb 2016
Director
Sold, plan not stated
2,600
$840.76K
21.4%
20 Feb 2015
Director
Sold, plan not stated
9,000
$2.82M
41.1%
20 Feb 2015
Director
Sold, plan not stated
6,000
$455.22K
16.3%
11 Aug 2014
Director
Sold, plan not stated
3,000
$782.67K
38.9%
13 Feb 2014
Director
Sold, plan not stated
6,000
$351.29K
17.6%
20 Nov 2012
Director
Sold, plan not stated
3,000
$539.13K
34.8%
28 Aug 2012
Director
Sold, plan not stated
1,300
$214.50K
19.2%
21 Aug 2012
Director
Sold, plan not stated
1,700
$282.08K
23.7%
10 Aug 2011
Director
Bought
1,000
$143.14K
13.7%
3 Mar 2011
Director
Sold, plan not stated
3,000
$526.68K
29.1%
2 Sep 2009
Director
Sold, plan not stated
1,000
$86.31K
20.4%
29 May 2008
Director
Sold, plan not stated
6,000
$382.42K
31.6%
21 May 2007
Director
Sold, plan not stated
16,000
$811.84K
59.3%
26 decisions on file.